{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:18:25Z","timestamp":1765887505156},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"S1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>As the amount of publicly available biomedical data increases, discovering hidden knowledge from biomedical data (i.e., Undiscovered Public Knowledge (UPK) proposed by Swanson) became an important research topic in the biological literature mining field. Drug indication inference, or drug repositioning, is one of famous UPK tasks, which infers alternative indications for approved drugs. Many previous studies tried to find novel candidate indications of existing drugs, but these works have following limitations: 1) models are not fully automated which required manual modulations to desired tasks, 2) are not able to cover various biomedical entities, and 3) have inference limitations that those works could infer only pre-defined cases using limited patterns. To overcome these problems, we suggest a new drug indication inference model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this paper, we adopted the Typed Network Motif Comparison Algorithm (TNMCA) to infer novel drug indications using topology of given network. Typed Network Motifs (TNM) are network motifs, which store types of data, instead of values of data. TNMCA is a powerful inference algorithm for multi-level biomedical interaction data as TNMs depend on the different types of entities and relations. We utilized a new normalized scoring function as well as network exclusion to improve the inference results. To validate our method, we applied TNMCA to a public database, Comparative Toxicogenomics Database (CTD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The results show that enhanced TNMCA was able to infer meaningful indications with high performance (AUC = 0.801, 0.829) compared to the ABC model (AUC = 0.7050) and previous TNMCA model (AUC = 0.5679, 0.7469). The literature analysis also shows that TNMCA inferred meaningful results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We proposed and enhanced a novel drug indication inference model by incorporating topological patterns of given network. By utilizing inference models from the topological patterns, we were able to improve inference power in drug indication inferences.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-6947-13-s1-s2","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T10:19:18Z","timestamp":1365157158000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Generation and application of drug indication inference models using typed network motif comparison analysis"],"prefix":"10.1186","volume":"13","author":[{"given":"Jaejoon","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwangmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doheon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,5]]},"reference":[{"key":"649_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1353\/pbm.1986.0087","volume":"30","author":"DR Swanson","year":"1986","unstructured":"Swanson DR: Fish oil, Raynaud's syndrome, and undiscovered public knowledge. Perspect Biol Med. 1986, 30: 7-18.","journal-title":"Perspect Biol Med"},{"key":"649_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/0002-9343(89)90261-1","volume":"86","author":"RA DiGiacomo","year":"1989","unstructured":"DiGiacomo RA, Kremer JM, Shah DM: Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study. Am J Med. 1989, 86: 158-164. 10.1016\/0002-9343(89)90261-1.","journal-title":"Am J Med"},{"key":"649_CR3","first-page":"1344","volume":"84","author":"D Hristovski","year":"2001","unstructured":"Hristovski D, Stare J, Peterlin B, Dzeroski S: Supporting discovery in medicine by association rule mining in Medline and UMLS. Stud Health Technol Inform. 2001, 84: 1344-1348.","journal-title":"Stud Health Technol Inform"},{"key":"649_CR4","volume-title":"Proceedings of the 2nd international conference on Knowledge capture; Sanibel Island, FL, USA","author":"W Pratt","year":"2003","unstructured":"Pratt W, Yetisgen-Yildiz M: LitLinker: capturing connections across the biomedical literature. Proceedings of the 2nd international conference on Knowledge capture; Sanibel Island, FL, USA. 2003, ACM"},{"issue":"Suppl 1","key":"649_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1472-6947-12-S1-S1","volume":"12","author":"S Lee","year":"2012","unstructured":"Lee S, Choi J, Park K, Song M, Lee D: Discovering context-specific relationships from biological literature by using multi-level context terms. BMC Med Inform Decis Mak. 2012, 12 (Suppl 1): S1-10.1186\/1472-6947-12-S1-S1.","journal-title":"BMC Med Inform Decis Mak"},{"key":"649_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","volume":"22","author":"JA DiMasi","year":"2003","unstructured":"DiMasi JA, Hansen RW, Grabowski HG: The price of innovation: new estimates of drug development costs. J Health Econ. 2003, 22: 151-185. 10.1016\/S0167-6296(02)00126-1.","journal-title":"J Health Econ"},{"key":"649_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR: The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006, 313: 1929-1935. 10.1126\/science.1132939.","journal-title":"Science"},{"key":"649_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/clpt.2009.103","volume":"86","author":"AP Chiang","year":"2009","unstructured":"Chiang AP, Butte AJ: Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clin Pharmacol Ther. 2009, 86: 507-510. 10.1038\/clpt.2009.103.","journal-title":"Clin Pharmacol Ther"},{"key":"649_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/msb.2011.26","volume":"7","author":"A Gottlieb","year":"2011","unstructured":"Gottlieb A, Stein GY, Ruppin E, Sharan R: PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol. 2011, 7: 496-","journal-title":"Mol Syst Biol"},{"key":"649_CR10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1145\/2390068.2390081","volume-title":"Proceedings of the ACM Sixth International Workshop on Data and Text Mining in Biomedical Informatics","author":"J Choi","year":"2012","unstructured":"Choi J, Kim K, Song M, Lee D: TNMCA: generation and application of network motif based inference models for drug repositioning. Proceedings of the ACM Sixth International Workshop on Data and Text Mining in Biomedical Informatics. 2012, New York: ACM, 61-68. 10.1145\/2390068.2390081."},{"key":"649_CR11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1126\/science.298.5594.824","volume":"298","author":"R Milo","year":"2002","unstructured":"Milo R, Shen-Orr S, Itzkovitz S, Kashtan N, Chklovskii D, Alon U: Network motifs: simple building blocks of complex networks. Science. 2002, 298: 824-827. 10.1126\/science.298.5594.824.","journal-title":"Science"},{"key":"649_CR12","first-page":"265","volume":"88","author":"CE Lipscomb","year":"2000","unstructured":"Lipscomb CE: Medical Subject Headings (MeSH). Bulletin of the Medical Library Association. 2000, 88: 265-266.","journal-title":"Bulletin of the Medical Library Association"},{"key":"649_CR13","doi-asserted-by":"publisher","first-page":"D1067","DOI":"10.1093\/nar\/gkq813","volume":"39","author":"AP Davis","year":"2011","unstructured":"Davis AP, King BL, Mockus S, Murphy CG, Saraceni-Richards C, Rosenstein M, Wiegers T, Mattingly CJ: The Comparative Toxicogenomics Database: update 2011. Nucleic Acids Res. 2011, 39: D1067-1072. 10.1093\/nar\/gkq813.","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 2","key":"649_CR14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1471-2105-11-S2-S3","volume":"11","author":"AZ Ijaz","year":"2010","unstructured":"Ijaz AZ, Song M, Lee D: MKEM: a Multi-level Knowledge Emergence Model for mining undiscovered public knowledge. BMC Bioinformatics. 2010, 11 (Suppl 2): S3-10.1186\/1471-2105-11-S2-S3.","journal-title":"BMC Bioinformatics"},{"key":"649_CR15","doi-asserted-by":"publisher","first-page":"D1035","DOI":"10.1093\/nar\/gkq1126","volume":"39","author":"C Knox","year":"2011","unstructured":"Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011, 39: D1035-1041. 10.1093\/nar\/gkq1126.","journal-title":"Nucleic Acids Res"},{"key":"649_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.tips.2009.11.006","volume":"31","author":"A Pujol","year":"2010","unstructured":"Pujol A, Mosca R, Farres J, Aloy P: Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol Sci. 2010, 31: 115-123. 10.1016\/j.tips.2009.11.006.","journal-title":"Trends Pharmacol Sci"},{"key":"649_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/FTD.0b013e318241ac71","volume":"34","author":"F Akhlaghi","year":"2012","unstructured":"Akhlaghi F, Dostalek M, Falck P, Mendonza AE, Amundsen R, Gohh RY, Asberg A: The concentration of cyclosporine metabolites is significantly lower in kidney transplant recipients with diabetes mellitus. Therapeutic drug monitoring. 2012, 34: 38-45. 10.1097\/FTD.0b013e318241ac71.","journal-title":"Therapeutic drug monitoring"},{"key":"649_CR18","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1161\/01.CIR.97.19.1912","volume":"97","author":"NS Kleiman","year":"1998","unstructured":"Kleiman NS, Lincoff AM, Kereiakes DJ, Miller DP, Aguirre FV, Anderson KM, Weisman HF, Califf RM, Topol EJ: Diabetes mellitus, glycoprotein IIb\/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators. Circulation. 1998, 97: 1912-1920. 10.1161\/01.CIR.97.19.1912.","journal-title":"Circulation"},{"key":"649_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cccn.2005.02.020","volume":"358","author":"R de Souza Santos","year":"2005","unstructured":"de Souza Santos R, Vianna LM: Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats. Clinica chimica acta; international journal of clinical chemistry. 2005, 358: 146-150. 10.1016\/j.cccn.2005.02.020.","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"649_CR20","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1046\/j.1523-1755.1999.0550031028.x","volume":"55","author":"F Wollesen","year":"1999","unstructured":"Wollesen F, Brattstrom L, Refsum H, Ueland PM, Berglund L, Berne C: Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney international. 1999, 55: 1028-1035. 10.1046\/j.1523-1755.1999.0550031028.x.","journal-title":"Kidney international"},{"key":"649_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1530\/eje.0.1420200","volume":"142","author":"S Diederich","year":"2000","unstructured":"Diederich S, Grossmann C, Hanke B, Quinkler M, Herrmann M, Bahr V, Oelkers W: In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I. European journal of endocrinology\/European Federation of Endocrine Societies. 2000, 142: 200-207. 10.1530\/eje.0.1420200.","journal-title":"European journal of endocrinology\/European Federation of Endocrine Societies"},{"key":"649_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1210\/endo-41-3-207","volume":"41","author":"DJ Ingle","year":"1947","unstructured":"Ingle DJ, Nezamis JE, Prestrud MC: The effect of diethylstilbestrol upon alloxan diabetes in the male rat. Endocrinology. 1947, 41: 207-212. 10.1210\/endo-41-3-207.","journal-title":"Endocrinology"},{"key":"649_CR23","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1126\/science.1128294","volume":"313","author":"U Ozcan","year":"2006","unstructured":"Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, Gorgun CZ, Hotamisligil GS: Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes. Science. 2006, 313: 1137-1140. 10.1126\/science.1128294.","journal-title":"Science"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-13-S1-S2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:49:35Z","timestamp":1630536575000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/1472-6947-13-S1-S2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":23,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["649"],"URL":"https:\/\/doi.org\/10.1186\/1472-6947-13-s1-s2","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"5 April 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"S2"}}